Remove Communication Remove Drug Development Remove Events
article thumbnail

Engaging change: Connecting patients and regulators can move the dial on drug development

pharmaphorum

Regulators are increasingly asking drug developers to include the patient voice in submissions, but the best way to go about this is less clear-cut. In the United States, learning how to navigate forums such as the FDA’s listening sessions and patient-focused drug development (PFDD) meetings could be the key to “truly moving the dial”.

article thumbnail

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

Pharmaceutical Technology

Many compounds present sub-optimal pharmacokinetic (PK) data (either predicted from in-vitro and pre-clinical data or measured in the clinic), such as poor exposure (leading to high doses), large variability, short half-life requiring more than once-a-day dosing, or C max -related adverse events (AEs).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Viseven’s Q2 Calendar: Unmissable Life Science Events 

Viseven

In the second quarter of 2024, the Viseven team embarked on a global journey, traversing continents to attend and participate in the world’s most prominent pharmaceutical events. Reuters Pharma EU 2024 April was a whirlwind for us, kicking off with the Reuters event in Barcelona where we went all out.

article thumbnail

Pharma’s Digital Leap: Generative AI and the Future of Drug Innovation

Pharma Leaders

This potential stems from accelerating drug discovery, streamlining development and approval processes, and optimizing marketing strategies—fundamentally reshaping the entire drug development lifecycle. This capability extends beyond initial drug discovery stages, encompassing clinical trials and post-approval monitoring.

article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

The decision was communicated through a Department of Health and Human Services (HHS) press release. Kennedy Jr.

article thumbnail

Clinical research in 2021: A new era of collaboration and innovation

pharmaphorum

The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development. It is likely we will begin to see the public ask more questions, which in turn may require more regular and ongoing communication efforts by industry stakeholders.

article thumbnail

Frontiers Health Steering Committee spotlight – Paul Tunnah

pharmaphorum

As the Frontiers Health 2022 conference in Milan on 20th to 21st October draws ever nearer, pharmaphorum has been catching up with members of the event’s Steering Committee to find out more about what drives both them and the event itself. The first of those had been Tunnah’s own springboard away from academia: communication.